XML 49 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholder's Equity (Tables)
12 Months Ended
Jul. 31, 2021
Equity [Abstract]  
Schedule of Capital Stock
Information as to the Company’s capital stock at July 31, 2021 and 2020 is as follows:
 July 31, 2021July 31, 2020
 Shares
Authorized
Shares
Issued
(thousands)
Amount
Shares
Authorized
Shares
Issued
(thousands)
Amount
Preferred Stock, $.01 par value5,000,000 5,000,000 
Cumulative Preferred Stock:
6% Cumulative
5,000 5,000 
1972 Series10,000 10,000 
1979 Series30,000 30,000 
Common Stock, $.01 par value: Class A Nonvoting100,000,000 51,261,487 $513 100,000,000 51,261,487 $513 
Class B Voting10,000,000 3,538,628 35 10,000,000 3,538,628 35 
$548 $548 
Schedule of Other Activity in Stockholders' Investment
The following is a summary of other activity in stockholders’ equity for the fiscal years ended July 31, 2021, 2020, and 2019:
Deferred CompensationShares Held in Rabbi Trust, at costTotal
Balances at July 31, 2018$8,222 $(8,222)$— 
Shares at July 31, 2018299,916 299,916 
Sale of shares at cost$(928)$928 $— 
Purchase of shares at cost1,212 (1,212)— 
Balances at July 31, 2019$8,506 $(8,506)$— 
Shares at July 31, 2019285,533 285,533 
Sale of shares at cost$(460)$460 $— 
Purchase of shares at cost1,293 (1,293)— 
Balances at July 31, 2020$9,339 $(9,339)$— 
Shares at July 31, 2020292,329 292,329 
Sale of shares at cost$(277)$277 $— 
Purchase of shares at cost1,472 (1,472)— 
Balances at July 31, 2021$10,534 $(10,534)$— 
Shares at July 31, 2021315,916 315,916 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:
Black-Scholes Option Valuation Assumptions202120202019
Expected term (in years)6.216.206.20
Expected volatility30.71 %26.07 %26.05 %
Expected dividend yield2.49 %2.63 %2.71 %
Risk-free interest rate0.38 %1.64 %3.01 %
Weighted-average market value of underlying stock at grant date$39.92 $54.05 $43.96 
Weighted-average exercise price$39.92 $54.05 $43.96 
Weighted-average fair value of options granted during the period$8.65 $10.63 $9.70 
Summary of Stock Option Activity under Company's Share-Based Compensation Plans
The following is a summary of stock option activity for the fiscal year ended July 31, 2021:
Time-Based OptionsOption PriceOptions OutstandingWeighted Average Exercise Price
Balance as of July 31, 2020$19.96 $54.051,273,382 $37.84 
New grants39.92303,052 39.92 
Exercised19.96 54.05(77,272)32.07 
Forfeited39.92 54.05(25,094)44.82 
Balance as of July 31, 2021$19.96 $54.051,474,068 $38.45 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The following table summarizes information about stock options outstanding at July 31, 2021:
 Options OutstandingOptions Outstanding and Exercisable
Range of Exercise PricesNumber of Shares Outstanding at July 31, 2021Weighted  Average Remaining Contractual Life (in years)Weighted Average Exercise PriceShares Exercisable at July 31, 2021Weighted Average Remaining Contractual Life (in years)Weighted Average Exercise Price
$19.96 - $29.99217,913 3.8$20.87 217,913 3.8$20.87 
$30.00 - $39.99789,608 6.637.05 501,997 5.235.40 
$40.00 - $54.05466,547 7.749.02 229,758 7.547.39 
Total1,474,068 6.5$38.45 949,668 5.4$34.97 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following tables summarize the RSU activity for the fiscal year ended July 31, 2021:
Time-Based RSUsSharesWeighted Average Grant Date
 Fair Value
Balance as of July 31, 2020154,960 $47.39 
New grants79,811 40.82 
Vested(69,436)44.48 
Forfeited(8,869)46.14 
Balance as of July 31, 2021156,466 $45.40 
The time-based RSUs granted during the fiscal year ended July 31, 2020 and 2019, had a weighted-average grant-date fair value of $53.38 and $44.20, respectively.
Performance-Based RSUsSharesWeighted Average Grant Date
 Fair Value
Balance as of July 31, 2020126,060 $50.61 
New grants (1)
64,634 60.73 
Vested (1)
(71,413)33.12 
Balance as of July 31, 2021119,281 $61.05 
(1) Includes 23,805 shares resulting from the payout of performance-based RSUs granted in fiscal year 2018 due to the achievement of performance metrics exceeding the target payout.